Disclaimer

PEMOLINE-ORAL, Cylert

NOTE: March 25, 2005, pemoline (Cylert) has been withdrawn from the market because of declining sales.

GENERIC NAME: PEMOLINE - ORAL (PEM-oh-leen)

BRAND NAME(S): Cylert

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: Pemoline should be used only after other treatments have failed. If this drug fails to work within a reasonable amount of time (within 3 weeks after ideal dosage has been determined) its use should be stopped. This medication has rarely caused severe (sometimes fatal) liver problems. Problems may occur even many months after starting use of this drug. If you notice early signs of liver problems, stop using this medication and contact your doctor promptly. Early signs of liver problems: yellowing of the eyes or skin, dark urine, severe stomach or abdominal pain, or unusual fatigue. Your doctor will monitor laboratory tests (e.g., liver function) before and during treatment. Your doctor should obtain a written consent form from you before you start treatment with this drug.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright


STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!